Literature DB >> 17055389

Update on botulinum toxin.

Timothy Corcoran Flynn1.   

Abstract

Botulinum toxin for facial enhancement is currently the most popular aesthetic procedure performed in the United States. New developments have occurred within the last few years. Patients prefer having multiple areas of the upper face treated which increases patient satisfaction. Treatment of the forehead is now being accomplished with fewer units of botulinum toxin. This helps preserve the natural look of some movement of the forehead. Men require more units of botulinum toxin than women. Combination therapy using botulinum toxin along with lasers or filler substances is ideal. Aesthetic medicine knowledge has progressed, contributing a greater understanding of botulinum treatment for advanced areas of the face. The orbicularis oris, mentalis, and depressor anguli oris are now routinely treated and help improve overall facial appearance. Other forms of botulinum toxins (additional type A or type B toxins) are available, each with advantages and disadvantages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055389     DOI: 10.1016/j.sder.2006.06.003

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  7 in total

1.  Topical botulinum toxin.

Authors:  Ashley Collins; Adnan Nasir
Journal:  J Clin Aesthet Dermatol       Date:  2010-03

2.  Topography and location of the depressor anguli oris muscle with a reference to the mental foramen.

Authors:  M S Hur; K S Hu; J Y Cho; H H Kwak; W C Song; K S Koh; M Lorente; H J Kim
Journal:  Surg Radiol Anat       Date:  2008-04-02       Impact factor: 1.246

3.  Selection and preference for botulinum toxins in the management of photoaging and facial lines: patient and physician considerations.

Authors:  Paul S Yamauchi
Journal:  Patient Prefer Adherence       Date:  2010-09-07       Impact factor: 2.711

Review 4.  Botulinum toxin: bioweapon & magic drug.

Authors:  Ram Kumar Dhaked; Manglesh Kumar Singh; Padma Singh; Pallavi Gupta
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

5.  Botulinum toxin - From WMD to therapeutic agent and cosmetic aid.

Authors:  Roger M Pinder
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

6.  Neurologic uses of botulinum neurotoxin type A.

Authors:  John P Ney; Kevin R Joseph
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

7.  OnabotulinumtoxinA Treatment for Moderate to Severe Forehead Lines: A Review.

Authors:  Koenraad De Boulle; Alastair Carruthers; Nowell Solish; Jean Carruthers; Wolfgang G Phillipp-Dormston; Steven Fagien; Sara Sangha; Michael Silberberg; Cheri Mao
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.